ESMO Immuno-Oncology Congress 2018: Information for Presenters

Please find here below instructions for the preparation of your presentation​ at the ESMO Immuno-Oncology Congress in Geneva

DOI: please complete or update any disclosures of interest you have prior to presenting at the Congress. To ensure due diligence you are required to outline the following:

  • Any interest that you have in the pharmaceutical, biotech or diagnostics commercial sector including but not limited to, speaking engagements, advisory roles, stock holdings or employment.

Invited Speaker and/or Chair

If you are an invited Speaker and/or Chair please refer to the instructions below and kindly return the completed DOI Form and Session Slide to us at doi@esmo.org by the 10th December 2018:

Oral Presentation

If your abstract has been accepted for Proffered paper (oral presentation) please refer to the instructions below:

Mini Oral

If your abstract has been accepted for Mini Oral please refer to the instructions below:

Poster Display

If your abstract has been accepted for Poster Display, please refer to the instructions below:

ESMO 2018 Poster Display Instructions